The National Immunisation Advisory Committee (NIAC) has made a key decision on the Johnson & Johnson vaccine – and has once again changed its advice on the AstraZeneca vaccine.
Whether it's good news or bad news depends on the position you start from. In light of the pause of the roll-out of the Johnson & Johnson vaccine, the HSE has been operating on the basis that it would not return.
From that perspective, it’s positive news that NIAC is advising that it can be used to vaccinate those over the age of 50 and those in hard-to-reach communities.
But the targets were set based on its full availability. In February, the Taoiseach said 55% of adults should be fully vaccinated by the end of June.